WUXI BIOLOGICS UNSP.ADR/2
Healthcare · EUR · F
Price
€6.872
Cap
€14.26B
Earnings
—
30d Trend
-5.8%
47% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 67×Macro 0.99 (−1%)=66
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Long-term compounder with 11.1% yield
BRAIN47'S ASSESSMENT
I rate WUXI BIOLOGICS UNSP.ADR/2 at 66/100 — a STRONG reading on the Brain47 Signal. The strongest factor is fundamentals at 85/100. I classify this as a income position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-4.6%
3 MONTHS
-19.6%
12 MONTHS
+20.0%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Long-term compounder with 11.1% yield. Fundamentals (85) and Momentum (73) are the primary strengths. I note that technical is the weakest area at 41/100 — this warrants monitoring. Historical volatility is elevated at 47%. I classify this as an income position — the 11.1% yield combined with the dividend profile makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.